[A study of combination chemotherapy with cis-diamminedichloroplatinum for advanced genitourinary carcinoma]. 1982

H Nakatsu, and K Nishimoto, and H Moriyama, and S Ehara, and M Igawa, and T Ishino, and M Kodama, and M Fujii, and R Ukai, and H Nihira

The patients with advanced testicular tumors and bladder carcinoma were treated by combination chemotherapies including cis-diamminedichloroplatinum. Four patients with advanced testicular tumors were treated with a combination chemotherapy, consisting of cis-diamminedichloroplatinum, vinblastine, and bleomycin or pepleomycin according to Einhorn's regimen. Three patients with advanced bladder carcinoma were treated with a combination chemotherapy consisting of cis-diamminedichloroplatinum, cyclophosphamide, and adriamycin according to Yagoda's regimen. These chemotherapy regimens produced 25% complete and 75% partial responses in testicular tumors and 100% of no change in bladder carcinoma. Although an overall response rate of three patients with bladder carcinoma was 0%, one patient was plateaustable for more than three months. We believe that the combination chemotherapy including cis-diamminedichloroplatinum is promising in the management of patients with advanced testicular tumors or bladder carcinoma.

UI MeSH Term Description Entries
D008297 Male Males
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Nakatsu, and K Nishimoto, and H Moriyama, and S Ehara, and M Igawa, and T Ishino, and M Kodama, and M Fujii, and R Ukai, and H Nihira
September 1984, Hinyokika kiyo. Acta urologica Japonica,
H Nakatsu, and K Nishimoto, and H Moriyama, and S Ehara, and M Igawa, and T Ishino, and M Kodama, and M Fujii, and R Ukai, and H Nihira
November 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
H Nakatsu, and K Nishimoto, and H Moriyama, and S Ehara, and M Igawa, and T Ishino, and M Kodama, and M Fujii, and R Ukai, and H Nihira
January 1984, Hinyokika kiyo. Acta urologica Japonica,
H Nakatsu, and K Nishimoto, and H Moriyama, and S Ehara, and M Igawa, and T Ishino, and M Kodama, and M Fujii, and R Ukai, and H Nihira
May 1984, Gan no rinsho. Japan journal of cancer clinics,
H Nakatsu, and K Nishimoto, and H Moriyama, and S Ehara, and M Igawa, and T Ishino, and M Kodama, and M Fujii, and R Ukai, and H Nihira
December 1984, Hinyokika kiyo. Acta urologica Japonica,
H Nakatsu, and K Nishimoto, and H Moriyama, and S Ehara, and M Igawa, and T Ishino, and M Kodama, and M Fujii, and R Ukai, and H Nihira
June 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
H Nakatsu, and K Nishimoto, and H Moriyama, and S Ehara, and M Igawa, and T Ishino, and M Kodama, and M Fujii, and R Ukai, and H Nihira
April 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
H Nakatsu, and K Nishimoto, and H Moriyama, and S Ehara, and M Igawa, and T Ishino, and M Kodama, and M Fujii, and R Ukai, and H Nihira
June 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
H Nakatsu, and K Nishimoto, and H Moriyama, and S Ehara, and M Igawa, and T Ishino, and M Kodama, and M Fujii, and R Ukai, and H Nihira
January 1984, Oncology,
H Nakatsu, and K Nishimoto, and H Moriyama, and S Ehara, and M Igawa, and T Ishino, and M Kodama, and M Fujii, and R Ukai, and H Nihira
October 1981, Gynecologic oncology,
Copied contents to your clipboard!